Pasithea Therapeutics Corp. (KTTA)

NCM – Real Time Price. Currency in USD

0.79

+0.01 (1.63%)

Market open: May 13, 2026, 2:17 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-663K

-649K

-648K

-5K

Gross Profit

-663K

-649K

-648K

-5K

Operating expenses (excl. COGS)

-20M

-14M

-15M

-13M

Operating Income

-21M

-14M

-16M

-13M

Non-operating income, total

430K

345K

472K

861K

Pretax income

-20M

-14M

-16M

-12M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-20M

-14M

-16M

-12M

Pasithea Therapeutics Corp. (KTTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pasithea Therapeutics Corp. (KTTA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pasithea Therapeutics Corp. (KTTA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pasithea Therapeutics Corp. (KTTA)

Income Statement (Annual)

Income Statement (Annual)